0

Activated Charcoal

Jason Silberman, Michael A. Galuska, Alan Taylor

PMID: 29493919

Abstract:

An oral suspension of activated charcoal (AC) should merit consideration in poisonings when there is an indication for gastrointestinal decontamination of an ingested toxin, and the clinician can administer activated charcoal within 1 hour of ingestion. Careful consideration of the contraindications (see below) should take place before treatment with activated charcoal. While activated charcoal has been shown to significantly reduce the absorption of many ingested toxins when given within the first-hour post-ingestion, there have been no studies to date that have shown patient-oriented outcome benefit such as mortality, morbidity, or length of hospital stay with the use of activated charcoal.

Chemicals Related in the Paper:

Catalog Number Product Name Structure CAS Number Price
AP7440440 Activated charcoal Activated charcoal 7440-44-0 Price
qrcode